YOU ARE LEAVING THE SITE
You are now leaving the site and moving to an external website independently operated and not managed by GSK. GSK assumes no responsibility for the site. If you do not wish to leave the site, click “Cancel.”
SELECT A CATEGORY
Access useful educational materials for your patients.
This site is intended for RSA healthcare professionals only.
© 2022 Haleon group of companies or its licensor. All rights reserved. Trade marks are owned by or licensed to the Haleon group of companies. This website is operated by GlaxoSmithKline Consumer Healthcare South Africa (Pty) Ltd (a Member of Haleon Group of Companies). 17 Muswell Road South, Block D, Wedgefield, Phase 2, Bryanston, Johannesburg, 2191, South Africa. Reg. No: 2014/173930/07. For any further information, including Human Safety Information (Adverse events/Product Quality Complaints) please contact the GSK CH SA hotline on +27 11 745 6001 or 0800007018 or email firstname.lastname@example.org. Always read the label, the leaflet or carton for full use instructions before use.
PM-ZA-PLD-20-00012Date of Preparation: May 2020PM-ZA-CNT-23-00066Date of Preparation: September 2023